Skip to main content

PROFUND ADVISORS LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in APLS

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$3,266,273
+$1,713,054 QoQ
Shares Held
81,190
+31.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#115
of 320 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. APLS ranks #5 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 APLS
Apellis Pharmaceuticals, Inc.
This page
81,190 $3,266,273

All Filings in APLS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,266,273 81,190
2025-12-31 $1,553,219 61,832
2025-09-30 $785,532 34,712
2025-06-30 $496,381 28,676
2025-03-31 $779,818 35,657
2024-12-31 $1,414,219 44,319
2024-09-30 $1,113,627 38,614
2024-06-30 $1,648,252 42,968
2024-03-31 $1,324,489 22,533
2023-12-31 $1,350,321 22,558
2023-09-30 $1,337,220 35,153
2023-06-30 $1,492,855 16,387
2023-03-31 $1,430,936 21,694
2022-12-31 $657,854 12,722
2022-09-30 $847,398 12,407